|
No (%)
|
Diagnosis | |
Non-functioning tumour | 44 (54) |
Gastrinoma | 23 (28) |
Calcitonin-secreting tumour | 7 (8) |
Glucagonoma | 4 (5) |
Insulinoma | 3 (3.5) |
Somatostatinoma | 1 |
Size of the primary tumour | |
< 3 cm | 34 (41.5) |
⩾ 3 cm | 48 (58.5) |
Primary tumour site1-150
| |
Pancreas | 62 (75.5) |
Duodenum | 13 (16) |
Peri-pancreatic lymph nodes | 7 (8.5) |
Patients with MEN I1-160
| 7 (8.5) |
Patients with metastases | |
Liver | 49 (60) |
Lymph nodes | 52 (63.5) |
Other1-165
| 15 (18.5) |
Progression of liver metastases | |
Yes | 27 (55) |
No | 4 (8) |
Non evaluated | 18 (37) |
Locoregional involvement | |
Yes | 26 (32) |
No | 56 (68) |
Tumour cell differentiation | |
Good | 64 (78) |
Poor | 9 (11) |
Non evaluated | 9 (11) |
Complete resection of the primary tumour | |
Yes | 42 (51) |
No | 40 (49) |